Lee's Pharmaceutical Holdings Limited Acquires Staccato® One Breath Technology® Platform and Assets, Driving Pipeline Expansion and Advancing Global Partnership with UCB Through Acquired Rights
* Acquisition of Staccato® One Breath Technology®, a proprietary platform technology with broad therapeutic potential * Synergistic and complementary to Lee's Pharm's existing products pipeline, and * Acquisition of rights as licensor and manufacturer of Staccato® alprazolam under a global ...
Lee's Pharm Supports Disaster Relief Efforts for Wang Fuk Court in Tai Po
HONG KONG, Dec. 1, 2025 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited (" Lee's Pharm" or the "Group", stock code: 0950.HK) expresses its deep condolences to the victims of the serious fire at Wang Fuk Court inTai Po, which caused multiple casualties and left many residents homeless and in ...
Lee's Pharm Announced 2020 Interim Results Positive Profit Alert
HONG KONG, Aug. 14, 2020 /PRNewswire/ -- Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group inChina, is pleased to announce that it is anticipated that the Group's will record a significant ...
GC Pharma and Lee's Pharm Enter into China Licensing Agreement to Develop and Commercialise GCC-4401C, an Investigational Anticoagulant
YONGIN, South Korea, Feb. 14, 2018 /PRNewswire/ -- GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Lee's Pharmaceutical (HK) Limited, a wholly-owned subsidiary of Lee's Pharmaceutical Holdings Limited ("Lee's Pharm") (SEHK: 0950) ...
Lee's Pharm 2015 Interim Profit Attributable to Equity Shareholders Up 18.3%
HONG KONG, Aug. 27, 2015 /PRNewswire/ -- Financial Highlight Six months ended 30 June (HK$'000) Change (%) 2015 2014 Turnover 477,903 442,716 +7.9% Gross Profit 337,829 311,467 +8.5% Profit Attributable to Equity Shareholders 103,026 87,073 +18.3% Basic Earni...
Lee's Pharmaceutical Announces 2013 Third Quarterly Results
Turnover and Net Profit Surged 32.0% and 30.3% Respectively HONG KONG, Nov. 28, 2013 /PRNewswire/ -- Financial Highlight (For the nine months ended 30 September) 2013 2012 Change (HK$'000) (HK$'000) ...
